Background. In Italy, the financial reimbursement for labile blood components exchanged between Regions is regulated by national tariffs defined in 1991 and updated in 1993-2003. Over the last five years, the need for establishing standard costs of healthcare services has arisen critically. In this perspective, the present study is aimed at defining both the costs of production of blood components and the related prices, as well as the prices of plasma-derived medicinal products obtained by national plasma, to be used for interregional financial reimbursement. Materials and methods. In order to analyse the costs of production of blood components, 12 out 318 blood establishments were selected in 8 Italian Regions. For each step of the produ...
Italy has had a national health service since 1978, to provide access to care to all citizens. The s...
Background: Congenital haemophilia A (HA) is a rare, inherited, life-long bleeding disorder characte...
Background: In an environment of limited healthcare resources, it is crucial for healthcare systems ...
(The economic value of blood components: what is the contribution of the cost accounting tools? A lo...
Background. In order to support the economic and financial sustainability of the Italian health syst...
© 2016 International Journal of the Economics of Business.Human blood plasma and its derivative ther...
Background:Plasma-derived medicinal products (PDMPs) represent a particular field of pharmaceutical ...
This paper presents cost-effectiveness analyses (CEAs) of plasma collection via two alternative meth...
The object of this review is to present and to shed light on joint cost-allocation methods that are ...
Background: Public cord blood banking is currently managed in Italy by a network of 19 regional cord...
Scarce information is available about the cost of mobilisation/collection of peripheral blood stem c...
Background. The overall production efficiency of plasmapheresis in Italy is significantly less than ...
Objectives: To calculate the costs of blood collection, testing, storage, and transfusion in Greece....
Background. Despite improvements in blood donor selection and screening procedures, transfusion reci...
In 1995 the Italian National Health Service begun to fund its hospitals on a per case basis, classif...
Italy has had a national health service since 1978, to provide access to care to all citizens. The s...
Background: Congenital haemophilia A (HA) is a rare, inherited, life-long bleeding disorder characte...
Background: In an environment of limited healthcare resources, it is crucial for healthcare systems ...
(The economic value of blood components: what is the contribution of the cost accounting tools? A lo...
Background. In order to support the economic and financial sustainability of the Italian health syst...
© 2016 International Journal of the Economics of Business.Human blood plasma and its derivative ther...
Background:Plasma-derived medicinal products (PDMPs) represent a particular field of pharmaceutical ...
This paper presents cost-effectiveness analyses (CEAs) of plasma collection via two alternative meth...
The object of this review is to present and to shed light on joint cost-allocation methods that are ...
Background: Public cord blood banking is currently managed in Italy by a network of 19 regional cord...
Scarce information is available about the cost of mobilisation/collection of peripheral blood stem c...
Background. The overall production efficiency of plasmapheresis in Italy is significantly less than ...
Objectives: To calculate the costs of blood collection, testing, storage, and transfusion in Greece....
Background. Despite improvements in blood donor selection and screening procedures, transfusion reci...
In 1995 the Italian National Health Service begun to fund its hospitals on a per case basis, classif...
Italy has had a national health service since 1978, to provide access to care to all citizens. The s...
Background: Congenital haemophilia A (HA) is a rare, inherited, life-long bleeding disorder characte...
Background: In an environment of limited healthcare resources, it is crucial for healthcare systems ...